U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818252) titled 'Efficacy Evaluation of Turmeric-Derived Nanoparticle Hydrogel for the Treatment of Diabeti... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placeb... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the tri... और पढ़ें
U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818785) titled 'The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That A... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A randomised phase III trial of adjuvant cemiplimab in patients with resected stage IIA-IIIB NSCL... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyro... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... और पढ़ें
Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... और पढ़ें